Rafat Abonour

  • 3552 Citations
  • 30 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

  • 3552 Citations
  • 30 h-Index
  • 78 Article
  • 8 Review article
  • 5 Letter
  • 3 Comment/debate
Filter
Letter
2016

Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Rifkin, R. M., Abonour, R., Shah, J. J., Mehta, J., Narang, M., Terebelo, H., Gasparetto, C., Toomey, K., Hardin, J. W., Lu, J. J., Kenvin, L., Srinivasan, S., Knight, R., Nagarwala, Y. & Durie, B. G. M., Sep 1 2016, In : Leukemia and Lymphoma. 57, 9, p. 2228-2231 4 p.

Research output: Contribution to journalLetter

14 Scopus citations

Disease-free survival following high dose or standard dose therapy in patients with amyloidosis

Kiel, P. J., Trueg, A. O., Ferguson, M., Benson, M. & Abonour, R., Jul 1 2016, In : British journal of haematology. 174, 1, p. 153-155 3 p.

Research output: Contribution to journalLetter

3 Scopus citations
2015

High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors

Ammakkanavar, N. R., Matei, D., Abonour, R. & Einhorn, L. H., Oct 10 2015, In : Journal of Clinical Oncology. 33, 2, p. 226-227 2 p.

Research output: Contribution to journalLetter

15 Scopus citations
2012

Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

Wolf, J. L., Siegel, D., Goldschmidt, H., Hazell, K., Bourquelot, P. M., Bengoudifa, B. R., Matous, J., Vij, R., De Magalhaes-Silverman, M., Abonour, R., Anderson, K. C. & Lonial, S., Sep 1 2012, In : Leukemia and Lymphoma. 53, 9, p. 1820-1823 4 p.

Research output: Contribution to journalLetter

100 Scopus citations